In cancer research, Dr. Clay Siegall is leading by example. The guy has a resume of success that extends back over 20 years. Siegall is the CEO of Seattle Genetics, which is a biotech company that specializes in the production of antibody-based therapies. Siegall is known all throughout the medical industry, and he is a man of many titles. In other words, he’s known to be a scientist, a doctor, a mentor and a businessman. The George Washington University graduate has worked with numerous medical organizations and pharmaceutical companies over the years such as Bayer and the National Institute of Health.
Seattle Genetics is one of the leading cancer research institutions in the world. It’s located in Seattle, Washington, and it has well-over 1,000 employees. The company’s top drug, ADCETRIS, is one of the very best cancer fighting medications in history. This is targeted treatment at its finest. ADCETRIS attacks cancerous cells within the body then gives it a cell-killing blow. On top of that, the good cells in the body aren’t harmed, which drastically cuts down on side effects. Siegall began this journey many years ago and the illness for one of his family members directed him into this field of work. He is very familiar with how cancer destroys the body over time and this is what fuels his passion. He is a natural-born philanthropist in a sense.
Seattle Genetics is a multimillion dollar organization, but it didn’t become profitable until about 10 years after its IPO. In the company’s earlier days, funds were being depleted left and right. This is a very demanding industry, but it showed Siegall that he had to work even more harder. As of today, the success of Seattle Genetics isn’t by chance, but rather by intuitive design.